Anika Therapeutics Inc — Cash Flow (NASDAQ:ANIK) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 13.06 M8.4 M4.41 M1.79 M5.4 M 8.13 M Cash from investing activities 71.26 M3.12 M7.49 M5.43 M8.33 M 1.91 M Cash from financing activities 3.77 M6.78 M4.85 M6.32 M12.73 M 10.63 M Free cash flow 11.44 M3.25 M-3.08 M-3.64 M-2.93 M 648 K

Haberler

Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates

Anika 2025年第四季度业绩:商业渠道激增抵消OEM业务下滑

Anika Q4 2025 slides: commercial surge offsets OEM decline

阿尼卡疗法有限公司Q4每股收益及营收超出预期

Anika earnings beat by $0.45, revenue topped estimates

Lumicell appoints Cheryl Blanchard to board of directors

Anika Therapeutics任命Stephen Griffin为新任首席执行官

Anika Therapeutics names Stephen Griffin as new CEO

安尼卡2025财年第三季度：商业渠道增长抵消OEM业务下滑

Anika Q3 2025 slides: Commercial growth offsets OEM decline

Anika Therapeutics (ANIK) Q3 Earnings and Revenues Top Estimates

Anika earnings beat by $0.22, revenue was in line with estimates